PharmaTech

APRIL 5, 2025

The authors examine the risks of extractables and leachables, and present solutions that emphasize the importance of a strategic, multi-prong approach.

52

52

Pharmacy Times

APRIL 5, 2025

Malow also emphasized the importance of staying educated on the potential neurological risks that may occur as a result of climate change.

39

39

STAT

APRIL 5, 2025

Medicare’s financial future unexpectedly got a lot rosier, at least according to some federal budget wonks.  The Congressional Budget Office recently published its long-term predictions of the federal budget and buried a big surprise for people who follow the Medicare program. The government’s primary piggy bank that pays for Medicare benefits won’t be depleted until 2052 — 17 years later than what CBO analysts predicted last year.

Hospitals 306

Hospitals 306

Pharmacy Times

APRIL 5, 2025

Beth A. Malow, MD, MS, FAAN, said that pharmacists and health care professionals are at the frontlines of collaborating and raising awareness of climate changes impacts.

29

29

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

APRIL 5, 2025

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

291

291

The Guardian - Pharmaceutical Industry

APRIL 5, 2025

Pharma firms are developing drugs that avoid the brains opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced In January, the US Food and Drug Administration (FDA) approved the first new type of painkiller in more than two decades. The decision roused excitement across the healthcare sector for a key reason: the drug, which is called suzetrigine and sold under the brand name Journavx, is not an opioid.

102

102

STAT

APRIL 5, 2025

At a time when the world is down to a single drug that can reliably cure gonorrhea, the U.S. government has shuttered the country’s premier sexually transmitted diseases laboratory, leaving experts aghast and fearful about what lies ahead. The STD lab at the Centers for Disease Control and Prevention — a leading player in global efforts to monitor for drug resistance in the bacteria that cause these diseases — was among the targets of major staff slashing at the CDC this pas

364

364